Additionally, we outline key knowledge gaps and suggest potential directions for future research, emphasizing the importance of CHIP as a potential biomarker and therapeutic target in the context of aging-related cerebrovascular and cognitive decline. This evidence concerns the gene STUB1 and Mental deterioration.